[Palliative treatment of hepatocellular carcinoma] (Q80052042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

[Palliative treatment of hepatocellular carcinoma] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

main subject

hepatocellular carcinoma

1 reference

Michel Doffoël

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Ahmed Ananna

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

Gastroenterologie Clinique et Biologique

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

6-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

887-890

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

Rising incidence of hepatocellular carcinoma in the United States

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Modeling the hepatitis C virus epidemic in France

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Prognosis of hepatocellular carcinoma: the BCLC staging classification

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Tamoxifen in the treatment of hepatocellular carcinoma: 5-year results of the CLIP-1 multicentre randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Use of tamoxifen in advanced-stage hepatocellular carcinoma. A systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0399-8320%2806%2973337-1

7 January 2021

10.1016/S0399-8320(06)73337-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16885874%20AND%20SRC:MED&resulttype=core&format=json